BBC news reported on Foamstream, the herbicide-free weed control product of Weedingtech, and its use across council parks and other public spaces. Leo de Montaignac, Chief Executive of Weedingtech, was quoted in the article: “I think that we’re only just seeing the very start of this market, and I think that over the next couple … Continued
Scancell, the developer of novel immunotherapies for the treatment of cancer, is pleased to announce that it has signed a collaboration and non-exclusive research agreement with a US-based, clinical stage antibody company to assess monoclonal antibodies (mAbs) targeting tumour-associated glycans (TaGs) including those that have been enhanced with Scancell’s proprietary AvidiMab™ technology. This is the … Continued
3.01.20 It was the year of Brexit (again), another bruising general election, and trauma in the retail fund industry with the demise of Woodford and the gating of property funds. Against this backdrop the VCT and EIS industry continued to grow in 2019, providing individuals with the opportunity to invest in exciting companies with the … Continued
Oxford BioTherapeutics Ltd. (“OBT”), a clinical stage oncology company developing antibody-based immuno-oncology therapies, has announced the initiation of the dose-escalation portion of its U.S. Phase I program for OBT076, a CD205 targeting antibody-drug conjugate (ADC), in patients with advanced solid tumours. Dose-escalation is the first part of the Phase I program that includes two U.S. … Continued
Calculus Capital has sold their investment in London-based marketing agency Once Upon a Time (OUAT) in a deal that netted investors an expected total return of 1.8x, excluding the tax benefits associated with investing through EIS. OUAT is a marketing agency that delivers the full range of marketing services; from advertising, branding, media, all forms … Continued
Calculus Capital has joined a £3.6 million funding round to support fast-growing accounts payable forensic software provider FISCAL Technologies. The money is the first external funding for the award-winning business, whose forensic software helps companies to identify areas of risk and fraud at every stage of the “purchase-to-pay” process. FISCAL, which is based in Reading, … Continued
Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces positive headline results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247. In the study, AT247 provided a favourable pharmacokinetic/pharmacodynamic profile compared with NovoRapid® and Fiasp®. AT247, an investigational novel meal-time insulin … Continued
Calculus Capital has extended its offer to waive initial fees on investments into its Venture Capital Trust (VCT) till December 12th. The move will allow investors to see their adviser before polling stations open. All three parties have published their manifestos and need to find the cash to pay for their spending plans. Labour and … Continued
Arecor, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces positive headline results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247. In the study, AT247 provided a favourable pharmacokinetic/pharmacodynamic profile compared with NovoRapid® and Fiasp®. AT247, an investigational novel meal-time insulin formulation, aims to significantly accelerate … Continued
Calculus Capital is delighted to announce its investment in Wonderhood Studios, the creative business founded by former Channel 4 CEO David Abraham and senior partners from the TV production and advertising sectors. Wonderhood is introducing a new hybrid model as a TV programme maker and advertising agency supported by a third capability which provides data-led … Continued